Navigation Links
Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
Date:5/10/2013

LAVAL, Quebec, May 10, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has provided additional information related to the proposal to continue Valeant into British Columbia (the "Continuance") under the British Columbia Business Corporations Act (the "BCBCA"). The Continuance is being presented for shareholder approval at Valeant's 2013 Annual Meeting of Shareholders to be held on Tuesday, May 21, 2013.

If the Continuance is approved by shareholders, Valeant's current Articles and By-laws under the Canada Business Corporations Act will be replaced with a Notice of Articles and Articles (the "New Articles") under the BCBCA.  As previously described in the Management Proxy Circular and Proxy Statement dated April 11, 2013 (the "Proxy Statement"), the New Articles provide that shareholders seeking to nominate candidates for election as directors must provide timely written notice to Valeant in accordance with the terms of the New Articles (the "Advance Notice Provision").

Valeant has modified the Advance Notice Provision to provide that, in the case of an annual general meeting, a shareholder's notice must be received by Valeant no later than the close of business on the 50th day before the meeting date; provided, however, that if the date (the "Notice Date") on which first public announcement of the date of the annual general meeting was made is less than 60 days prior to the date of the annual general meeting, a shareholder's notice must be received by Valeant no later than the close of business on the 10th day following the Notice Date.

Valeant has supplemented its Proxy Statement to reflect the revision to the Advance Notice Provision.

About Valeant Pharmaceuticals International, Inc.

Va
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Provides Efinconazole Update
2. Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
3. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
4. Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
5. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
6. Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
7. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
8. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
9. Valeant Pharmaceuticals Provides Update to Recent Event
10. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
11. Valeant Pharmaceuticals Announces Private Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- NEOVIA ONCOLOGY Ltd. http://www.neoviaoncology.com/ a ... commercialization of novel, multi-function drugs for overcoming drug-resistant ... U.S. Food and Drug Administration (FDA) to discuss ... Drug (IND) application for its lead compound NEV-801. ... Neovia has clarified details of the development path ...
(Date:6/1/2015)... CHICAGO, Ill. , June 1, 2015  AbbVie ... 2015 Healthcare Conference on Thursday, June 4, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:6/1/2015)... 1, 2015 NSHOA Cancer Center and ... announced positive, top-line results from its recently completed ... and safety of the Company,s 5-HT 3 ... injection, extended release) as part of a three-drug ... ) receptor antagonist fosaprepitant and the IV corticosteroid ...
Breaking Medicine Technology:Neovia Oncology Announces First IND Meeting 2New cancer therapy study results - MAGIC Trial 2
... MILPITAS, Calif., June 13, 2011 AmbiCom Holdings, Inc. ... products for medical equipment suppliers, today announced that it ... between its AmbiCom Technology, Inc. ("ATI") subsidiary and E-Care ... 1, 2011 and runs for a period of three ...
... Inc., (NASDAQ: HSIC ), the largest provider of ... announced today that Stanley M. Bergman, Chairman and Chief Executive ... Vice President and Chief Financial Officer, will present at William ... at the Four Seasons Hotel in Chicago. ...
Cached Medicine Technology:AmbiCom Forms Joint Alliance With E-Care Technology Corporation 2AmbiCom Forms Joint Alliance With E-Care Technology Corporation 3Henry Schein to Present at the William Blair 31st Annual Growth Stock Conference 2
(Date:6/1/2015)... The National Association of Professional Women ... (C), First Sergeant A Co., 15BSB , as a ... Circle. She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more than ... “I'm pleased to recognize Sergeant Cornett with this important ...
(Date:6/1/2015)... 01, 2015 Carson Energy also announced ... investors IRA transactions. AdvantaIRA Trust, LLC is the country’s ... ability to fund positions using IRA’s does 2 things:, ... a project, even if there current cash position will ... funding source for Carson and their investors to be ...
(Date:6/1/2015)... New York (PRWEB) June 01, 2015 ... http://www.testosteronelawsuithub.com/ ) has amended the Case Management Order ... AndroGel testosterone gel. The Amended Order which was ... Illinois on May 29, 2015, directs the parties to ... by August 10, 2015 that outlines parameters and the ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Atagi Plastic ... have been named an Ultherapy® Ultra Treatment ... Surgery and Skin Aesthetics is one of only six ... a premier treatment provider. , Atagi Plastic Surgery ... the Denver area has led the practice to earn ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. ... first she thought it was just a part of getting ... than that. After going to the doctor, she received a ... about what might happen to her. , Linda is not ... valve disease each year. Valve disease involves damage to one ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3
... THRM ) today announced that its S-4 Registration ... proposed acquisition of,Reliant, Inc., has been declared effective. The ... 2008 to shareholders of record as of October 31,2008. ... 23 for a meeting of its,shareholders to vote on ...
... Nov. 24 James M. Golubieski, president of Foundation Venture Capital ... the company has made a $500,000 commitment to Longevica Pharmaceuticals, Inc., ... cells healthy during chemotherapy or radiation treatments. , ... University of Medicine and Dentistry of New Jersey . ...
... pediatric research institution , ... Washington, DC (Vocus) November ... Research Institute , dedicated new research facilities today, increasing the space ... than 100,000 square feet. , , , , ,Elected officials and ...
... focus on radiology IT drives a strong return on investment ... Nov. 24 AMICAS, Inc. (Nasdaq: AMCS ), ... solutions, today announced that it will highlight the AMICAS ONE ... cycle management, teleradiology, and document management, at the 2008 Radiological ...
... Health Plan Forecaster, Medicare shoppers can compare and enroll ... , NEW YORK, Nov. 24 The ... the holiday shopping rush. For seniors and their families ... better time to "shop" for coverage using the award-winning ...
... Adding it to clot-busting drug eased the blockages, study found ... ultrasound waves and clot-busting drugs may help dissolve blood clots ... (DVT), according to an Emory University School of Medicine study. ... a vein deep in the body, most often in the ...
Cached Medicine News:Health News:Thermage Schedules Shareholder Meeting for Vote on the Issuance of Common Stock in Connection With the Reliant Acquisition 2Health News:Foundation Venture Capital Group Invests in Company Working to Protect Healthy Tissue During Cancer Treatment 2Health News:Children's National Dedicates New Research Facility 2Health News:Children's National Dedicates New Research Facility 3Health News:AMICAS Showcases Comprehensive Image and Information Management Solution Suite at RSNA 2Health News:AMICAS Showcases Comprehensive Image and Information Management Solution Suite at RSNA 3Health News:bWell-informed(TM) Adds Medicare Plan Tools for 2008 Open Enrollment Season 2Health News:Ultrasound Can Help Break Up DVTs 2
... German Craftsmanship have produced the ... world. Ocutek® now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: